Marijuana shows real promise for arthritis pain, but the evidence is still limited. The best clinical trial to date found that a THC/CBD spray reduced pain scores by about 1 point on a 10-point scale compared to placebo in people with rheumatoid arthritis, along with modest improvements in joint function and sleep quality. That’s a meaningful difference for daily comfort, though it falls short of what most standard arthritis treatments deliver. The honest answer is that cannabis probably helps some people feel better, but it’s not a proven treatment for the disease itself.
How Cannabis Affects Inflamed Joints
Your joints are lined with a tissue called the synovium, and in arthritis, that lining becomes a battleground of inflammation. Cells in inflamed synovial tissue ramp up production of a specific receptor (called CB2) that cannabinoids can activate. When this receptor is triggered, it shifts immune cells in the joint away from their inflammatory state and reduces the production of enzymes that break down cartilage, along with key inflammatory signals like interleukin-6.
CBD appears to work through a similar pathway, pushing immune cells toward a less destructive profile. This isn’t just theoretical: lab studies using human joint tissue from osteoarthritis patients show that activating this receptor suppresses multiple inflammatory signals at once. The biology is genuinely encouraging. The gap is between what happens in a lab dish and what happens when someone takes a gummy or uses a tincture for their knee pain.
What Clinical Trials Actually Show
Rigorous human evidence is surprisingly thin. The most cited trial tested an oral spray containing roughly equal parts THC and CBD in 58 people with rheumatoid arthritis over five weeks. Patients using the spray reported less pain during movement and at rest, along with better sleep. However, morning stiffness, one of the hallmark symptoms of RA, did not improve.
For osteoarthritis, the picture is even less clear. A 12-week trial of low-dose synthetic CBD (20 to 30 mg per day) in people with hand osteoarthritis found no significant difference from placebo for pain, sleep, anxiety, or depression. Some researchers have argued the dose was simply too low, and a separate trial used 600 mg per day of CBD, but experts caution that jumping to high fixed doses ignores how differently individuals respond to cannabinoids based on factors like sex, genetics, body weight, and medication use.
No clinical trial has shown that cannabis slows joint damage or alters the progression of any form of arthritis. This is a critical distinction. Feeling less pain is valuable, but it’s not the same as protecting your joints from further destruction.
Rheumatoid Arthritis vs. Osteoarthritis
These are fundamentally different diseases, and cannabis may not work the same way for both. Rheumatoid arthritis is driven by an overactive immune system attacking joint tissue, which is where the anti-inflammatory properties of cannabinoids are most theoretically relevant. The CB2 receptors that cannabinoids target are concentrated on the immune cells flooding into inflamed RA joints.
Osteoarthritis involves mechanical wear and breakdown of cartilage, with inflammation playing a secondary role. The limited trial data for osteoarthritis has been disappointing so far. That doesn’t mean cannabis won’t help with OA pain, since pain relief and anti-inflammatory effects are separate things, but the biological case is stronger for inflammatory arthritis types.
How Different Forms Compare
The way you take cannabis changes what it does and how quickly it works. Inhaled cannabis (smoked or vaporized) kicks in within 5 to 10 minutes and lasts 2 to 4 hours. Oral products like edibles take 1 to 3 hours to take effect but last 6 to 8 hours or longer. Sublingual oils held under the tongue for a minute or two fall in between, typically working within 15 to 45 minutes and lasting 6 to 8 hours.
Topical creams and salves are the most popular choice for localized joint pain, but the evidence for them is the weakest. CBD is a fatty molecule that tends to accumulate in the upper layers of skin without penetrating deeply enough to reach the joint unless the product includes a specialized carrier system designed to push it through. Most over-the-counter CBD creams have not been tested for whether they actually deliver meaningful amounts of cannabinoid to joint tissue. Some people report relief, but it’s unclear whether that’s a true pharmacological effect or a placebo response combined with the massaging action of applying the cream. Experts generally recommend oral or sublingual preparations over inhalation, which causes respiratory damage over time.
Drug Interactions With Arthritis Medications
This is where cannabis gets complicated for arthritis patients specifically. Cannabinoids interfere with liver enzymes that your body uses to break down many common arthritis drugs, which can cause those medications to build up to higher-than-intended levels in your blood.
- Corticosteroids (prednisone): Cannabis slows their clearance, potentially increasing side effects like blood sugar spikes, fluid retention, and bone thinning.
- NSAIDs (ibuprofen, naproxen): Cannabinoids can raise circulating levels of these drugs, increasing the risk of stomach and kidney problems.
- Tramadol: Cannabis blocks the enzyme that converts tramadol into its active pain-relieving form, potentially making it less effective.
- Gabapentin and pregabalin: Combining these with cannabis can cause additive sedation, raising the risk of falls and drowsiness.
- Amitriptyline: Cannabis inhibits multiple enzymes responsible for clearing this drug, increasing the risk of heart rhythm changes and other side effects.
If you’re on any of these medications, adding cannabis without discussing it with your prescriber could change how your existing drugs behave in your body.
Safety Concerns for Older Adults
Most people with arthritis are over 50, which introduces specific risks. A study comparing older cannabis users to non-users found that users had a 91% higher probability of falling, along with worse standing balance and slower walking speed. These effects appear to compound the balance and gait problems that already come with aging.
Notably, the participants in that study were using capsules and tinctures, not smoking. So these balance effects aren’t limited to getting “high” in the traditional sense. Even CBD-containing products contributed to the pattern. For someone already dealing with joint instability from arthritis, a fall can mean a fracture, surgery, or a long recovery that worsens overall mobility. The consensus recommendation for older adults considering cannabis is to start with the lowest possible dose and increase slowly over weeks.
What the Arthritis Foundation Recommends
The Arthritis Foundation has taken a cautiously open position on CBD. Their guidance acknowledges that CBD may help with arthritis-related pain, insomnia, and anxiety, but stresses that no rigorous clinical trials in arthritis patients have confirmed these benefits. Their key recommendations: CBD should never replace disease-modifying drugs that prevent permanent joint damage in inflammatory arthritis. Start with a low dose and increase in small increments weekly. Buy only from companies that provide independent lab testing with a certificate of analysis for each batch, since the CBD market remains poorly regulated and many products contain more or less CBD than their labels claim.
The Foundation has formally urged the FDA to accelerate the study and regulation of CBD products, a signal that they see enough potential to want better evidence rather than dismissing it outright. For now, cannabis sits in a gray zone: biologically plausible, modestly supported by early trials, but far from established as a standard arthritis treatment.